259 related articles for article (PubMed ID: 25336703)
1. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
2. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
3. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
4. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
6. Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men.
Kristiansen W; Aschim EL; Andersen JM; Witczak O; Fosså SD; Haugen TB
Int J Androl; 2012 Dec; 35(6):819-827. PubMed ID: 22882535
[TBL] [Abstract][Full Text] [Related]
7. Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.
Eberhard J; Ståhl O; Cohn-Cedermark G; Cavallin-Ståhl E; Giwercman Y; Rastkhani H; Rylander L; Eberhard-Gran M; Kvist U; Giwercman A
J Affect Disord; 2010 May; 122(3):260-6. PubMed ID: 19656574
[TBL] [Abstract][Full Text] [Related]
8. A 5α-reductase (SRD5A2) polymorphism is associated with serum testosterone and sex hormone-binding globulin in men, while aromatase (CYP19A1) polymorphisms are associated with oestradiol and luteinizing hormone reciprocally.
Yeap BB; Knuiman MW; Handelsman DJ; Ho KKY; Hui J; Divitini ML; Arscott GM; McQuillan B; Hung J; Beilby JP
Clin Endocrinol (Oxf); 2019 Feb; 90(2):301-311. PubMed ID: 30353958
[TBL] [Abstract][Full Text] [Related]
9. Compensated reduction in Leydig cell function is associated with lower semen quality variables: a study of 8182 European young men.
Jørgensen N; Joensen UN; Toppari J; Punab M; Erenpreiss J; Zilaitiene B; Paasch U; Salzbrunn A; Fernandez MF; Virtanen HE; Matulevicius V; Olea N; Jensen TK; Petersen JH; Skakkebæk NE; Andersson AM
Hum Reprod; 2016 May; 31(5):947-57. PubMed ID: 26936886
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men.
Huhtaniemi IT; Pye SR; Holliday KL; Thomson W; O'Neill TW; Platt H; Payne D; John SL; Jiang M; Bartfai G; Boonen S; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Vanderschueren D; Labrie F; Wu FC;
J Clin Endocrinol Metab; 2010 Apr; 95(4):1898-908. PubMed ID: 20173016
[TBL] [Abstract][Full Text] [Related]
11. PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men.
Joensen UN; Veyrand B; Antignac JP; Blomberg Jensen M; Petersen JH; Marchand P; Skakkebæk NE; Andersson AM; Le Bizec B; Jørgensen N
Hum Reprod; 2013 Mar; 28(3):599-608. PubMed ID: 23250927
[TBL] [Abstract][Full Text] [Related]
12. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
Nord C; Bjøro T; Ellingsen D; Mykletun A; Dahl O; Klepp O; Bremnes RM; Wist E; Fosså SD
Eur Urol; 2003 Sep; 44(3):322-8. PubMed ID: 12932930
[TBL] [Abstract][Full Text] [Related]
13. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study.
Oldenburg J; Kraggerud SM; Brydøy M; Cvancarova M; Lothe RA; Fossa SD
J Transl Med; 2007 Dec; 5():70. PubMed ID: 18162130
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
Kristiansen W; Haugen TB; Witczak O; Andersen JM; Fosså SD; Aschim EL
Int J Androl; 2011 Feb; 34(1):77-83. PubMed ID: 20345875
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
[TBL] [Abstract][Full Text] [Related]
16. Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics.
Macdonald AA; Stewart AW; Farquhar CM
Hum Reprod; 2013 Dec; 28(12):3178-87. PubMed ID: 24129611
[TBL] [Abstract][Full Text] [Related]
17. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
19. The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
Giwercman YL; Abrahamsson PA; Giwercman A; Gadaleanu V; Ahlgren G
Eur Urol; 2005 Oct; 48(4):679-85. PubMed ID: 16039774
[TBL] [Abstract][Full Text] [Related]
20. Anogenital distance is associated with serum reproductive hormones, but not with semen quality in young men.
Zhou N; Sun L; Yang H; Chen Q; Wang X; Yang H; Tan L; Chen H; Zhang G; Ling X; Huang L; Zou P; Peng K; Liu T; Liu J; Ao L; Zhou Z; Cui Z; Cao J
Hum Reprod; 2016 May; 31(5):958-67. PubMed ID: 27052617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
